Powder: -20°C for 3 years | In solvent: -80°C for 1 year
COX-2-IN-6 是一种具有有效性、选择性且可口服的环氧化酶-2 (COX-2) 抑制剂,对 COX-2 具有抑制作用,IC50 为 0.84 μM,Ki 为 69 nM。COX-2-IN-6 对 COX-2 驱动的 PGE2 合成具有抑制作用,IC50 为 0.60 μM。COX-2-IN-6 可用于预防结直肠癌。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 753 | 现货 | ||
5 mg | ¥ 1,660 | 现货 | ||
10 mg | ¥ 2,820 | 现货 | ||
25 mg | ¥ 4,680 | 现货 | ||
50 mg | ¥ 6,680 | 现货 | ||
100 mg | ¥ 8,920 | 现货 | ||
500 mg | ¥ 18,200 | 现货 |
产品描述 | COX-2-IN-6 is a potent, selective, and orally available cyclooxygenase-2 (COX-2) inhibitor with an IC50 of 0.84 μM and a Ki of 69 nM.COX-2-IN-6 inhibits COX-2-driven PGE2 synthesis with an IC50 of 0.60 μM.COX-2-IN-6 is used to prevent colorectal cancer. COX-2-IN-6 can be used to prevent colorectal cancer. |
靶点活性 | COX-2:0.84 μM |
体外活性 |
COX-2-IN-6 (Compound 10) inhibits human COX-2/COX-1 enzyme and COX-2/COX-1-driven PGE2 synthesis in HEK293 cells, with IC50 of 0.84 μM、>50 μM、0.60 μM and, >50 μM, respectively.[1] COX-2-IN-6 exhibits stability in human or mouse liver microsomes and hepatocytes in vitro. The T1/2 value of human hepatocytes is 3.1 min, and the T1/2 value of mouse hepatocytes is 3.0 min.[1] |
体内活性 |
COX-2-IN-6 (Compound 10) (30, 100, 300 mg/kg; oral; single dose; APCmin/mouse model) inhibits adenoma progression and extends survival in the APCmin/+ mouse model.[1] COX-2-IN-6 (10 mg/kg; oral; single dose; APCmin/+ mouse model) exhibits high colonic exposure (>4300 ng/g) and low systemic exposure (<6 ng/mL), C/P distribution ratio > 1200 in 4 hours.[1] |
分子量 | 409.5 |
分子式 | C20H27NO6S |
CAS No. | 2756347-91-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 40.95 mg/mL (100 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.442 mL | 12.21 mL | 24.42 mL | 61.0501 mL |
5 mM | 0.4884 mL | 2.442 mL | 4.884 mL | 12.21 mL | |
10 mM | 0.2442 mL | 1.221 mL | 2.442 mL | 6.105 mL | |
20 mM | 0.1221 mL | 0.6105 mL | 1.221 mL | 3.0525 mL | |
50 mM | 0.0488 mL | 0.2442 mL | 0.4884 mL | 1.221 mL | |
100 mM | 0.0244 mL | 0.1221 mL | 0.2442 mL | 0.6105 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
COX-2-IN-6 2756347-91-6 GPCR/G Protein Immunology/Inflammation Neuroscience COX Prostaglandin Receptor Inhibitor inhibitor inhibit